Biomolecules & Therapeutics

  • 제32권6호
  • /
  • Pages.659-684
  • /
  • 2024
  • /
  • 1976-9148(pISSN)
  • /
  • 2005-4483(eISSN)
한국응용약물학회 (The Korean Society of Applied Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine

  • Eun-Sook Park (Institute of Biomedical Science and Technology, School of Medicine, Konkuk University) ;
  • Chan Young Shin (School of Medicine and Center for Neuroscience Research, Konkuk University) ;
  • Se Jin Jeon (Department of Pharmacology, College of Medicine, Hallym University) ;
  • Byung-Joo Ham (Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine)
  • 투고 : 2024.09.10
  • 심사 : 2024.10.07
  • 발행 : 2024.11.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Viral infections are increasingly recognized as triggers for depressive disorders, particularly following the SARS-CoV-2 pandemic and the rise of long COVID. Viruses such as Herpes Simplex Virus (HSV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV), and Human Immunodeficiency Virus (HIV) are linked to depression through complex neurobiological mechanisms. These include immune system dysregulation, chronic inflammation, and neurotransmitter imbalances that affect brain function and mood regulation. Viral activation of the immune system leads to the release of pro-inflammatory cytokines, resulting in neuroinflammation and associated depressive symptoms. Furthermore, specific viruses can disrupt neurotransmitter systems, including serotonin, dopamine, and glutamate, all of which are essential for mood stabilization. The unique interactions of different viruses with these systems underscore the need for virus-specific therapeutic approaches. Current broad-spectrum treatments often overlook the precise neurobiological pathways involved in post-viral depression, reducing their efficacy. This review emphasizes the need to understand these virus-specific interactions to create tailored interventions that directly address the neurobiological effects induced by each type of virus. These interventions may include immunomodulatory treatments that target persistent inflammation, antiviral therapies to reduce the viral load, or neuroprotective strategies that restore neurotransmitter balance. Precision medicine offers promising avenues for the effective management of virus-induced depression, providing patient-specific approaches that address the specific biological mechanisms involved. By focusing on the development of these targeted treatments, this review aims to pave the way for a new era in psychiatric care that fully addresses the root causes of depression induced by viral infections.

키워드

과제정보

This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government by the Ministry of Education (NRF-2020M3E5D9080165, 2020M3E5D9080794, NRF-2022R1F1A1074517 and NRF-2022R1A2C2002809).

참고문헌

  1. Acharjee, S., Branton, W. G., Vivithanaporn, P., Maingat, F., Paul, A. M., Dickie, P., Baker, G. B. and Power, C. (2014) HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain Behav. Immun. 40, 74-84.
  2. Adeoluwa, O. A., Olayinka, J. N., Adeoluwa, G. O., Akinluyi, E. T., Adeniyi, F. R., Fafure, A., Nebo, K., Edem, E. E., Eduviere, A. T. and Abubakar, B. (2023) Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3/NFκB/iNOS signaling pathway. Behav. Brain Res. 450, 114503.
  3. Adhya, D. and Basu, A. (2010) Epigenetic modulation of host: new insights into immune evasion by viruses. J. Biosci. 35, 647-663.
  4. Adinolfi, L. E., Nevola, R., Lus, G., Restivo, L., Guerrera, B., Romano, C., Zampino, R., Rinaldi, L., Sellitto, A., Giordano, M. and Marrone, A. (2015) Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J. Gastroenterol. 21, 2269-2280.
  5. Alamer, E., Zhong, C., Liu, Z., Niu, Q., Long, F., Guo, L., Gelman, B. B., Soong, L., Zhou, J. and Hu, H. (2020) Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580. J. Virol. 94, e01880.
  6. Allen, A. D. and Tilkian, S. M. (1986) Depression correlated with cellular immunity in systemic immunodeficient Epstein-Barr virus syndrome (SIDES). J. Clin. Psychiatry 47, 133-135.
  7. Allen, J., Romay-Tallon, R., Brymer, K. J., Caruncho, H. J. and Kalynchuk, L. E. (2018) Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front. Neurosci. 12, 386.
  8. Allison, D. J., Sharma, B. and Timmons, B. W. (2019) The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: a systematic review of randomized clinical trials. Physiol. Behav. 207, 104-112.
  9. Amendola-Pires, M. M., Fakoury, M. K., Salazar, H., De Oliveira, S. B., Brandao-Mello, C. E. and Schmidt, S. L. (2023) Hepatitis C Virus (HCV) infection and neurocognitive impairment in subjects with mild liver disease. J. Clin. Med. 12, 3910.
  10. Amsterdam, J. D. and Hernz, W. J. (1993) Serum antibodies to herpes simplex virus types I and II in depressed patients. Biol. Psychiatry 34, 417-420.
  11. Anisman, H., Ravindran, A. V., Griffiths, J. and Merali, Z. (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol. Psychiatry 4, 182-188.
  12. Atluri, V. S., Kanthikeel, S. P., Reddy, P. V., Yndart, A. and Nair, M. P. (2013) Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One 8, e61399.
  13. Avdoshina, V., Bachis, A. and Mocchetti, I. (2013) Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity? J. Intern. Med. 273, 454-465.
  14. Averill, L. A., Jiang, L., Purohit, P., Coppoli, A., Averill, C. L., Roscoe, J., Kelmendi, B., De Feyter, H. M., de Graaf, R. A., Gueorguieva, R., Sanacora, G., Krystal, J. H., Rothman, D. L., Mason, G. F. and Abdallah, C. G. (2022) Prefrontal glutamate neurotransmission in PTSD: a novel approach to estimate synaptic strength in vivo in humans. Chronic Stress (Thousand Oaks) 6, 24705470221092734.
  15. Ayano, G., Demelash, S., Abraha, M. and Tsegay, L. (2021) The prevalence of depression among adolescent with HIV/AIDS: a systematic review and meta-analysis. AIDS Res. Ther. 18, 23.
  16. Ayano, G., Solomon, M. and Abraha, M. (2018) A systematic review and meta-analysis of epidemiology of depression in people living with HIV in East Africa. BMC Psychiatry 18, 254.
  17. Ayling, K., Jia, R., Coupland, C., Chalder, T., Massey, A., Broadbent, E. and Vedhara, K. (2022) Psychological predictors of self-reported COVID-19 outcomes: results from a prospective cohort study. Ann. Behav. Med. 56, 484-497.
  18. Bai, S., Guo, W., Feng, Y., Deng, H., Li, G., Nie, H., Guo, G., Yu, H., Ma, Y., Wang, J., Chen, S., Jing, J., Yang, J., Tang, Y. and Tang, Z. (2020) Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. J. Neurol. Neurosurg. Psychiatry 91, 21-32.
  19. Barlow-Mosha, L., Eckard, A. R., McComsey, G. A. and Musoke, P. M. (2013) Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J. Int. AIDS Soc. 16, 18600.
  20. Bartolomeo, C. S., Lemes, R. M. R., Morais, R. L., Pereria, G. C., Nunes, T. A., Costa, A. J., de Barros Maciel, R. M., Braconi, C. T., Maricato, J. T., Janini, L. M. R., Okuda, L. H., Lee, K. S., Prado, C. M., Ureshino, R. P. and Stilhano, R. S. (2022) SARS-CoV-2 infection and replication kinetics in different human cell types: the role of autophagy, cellular metabolism and ACE2 expression. Life Sci. 308, 120930.
  21. Battaglia, D. M., Sanchez-Pino, M. D., Nichols, C. D. and Foster, T. P. (2022) Herpes simplex virus-1 induced serotonin-associated metabolic pathways correlate with severity of virus- and inflammation-associated ocular disease. Front. Microbiol. 13, 859866.
  22. Bavaresco, D. V., Uggioni, M. L. R., Ferraz, S. D., Marques, R. M. M., Simon, C. S., Dagostin, V. S., Grande, A. J. and da Rosa, M. I. (2020) Efficacy of infliximab in treatment-resistant depression: a systematic review and meta-analysis. Pharmacol. Biochem. Behav. 188, 172838.
  23. Bayturan, S., Sapmaz, S. Y., Uzun, A. D., Kandemir, H. and Ecemis, T. (2022) Relationship of herpesvirus (HSV1, EBV, CMV, HHV6) seropositivity with depressive disorder and its clinical aspects: the first study in children. J. Med. Virol. 94, 5484-5491.
  24. Beharry, M. (2022) Pediatric anxiety and depression in the time of COVID-19. Pediatr. Ann. 51, e154-e160.
  25. Berger, J. R., Kumar, M., Kumar, A., Fernandez, J. B. and Levin, B. (1994) Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 8, 67-71.
  26. Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. and Sousa, N. (2009) The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol. Psychiatry 14, 764-773, 739.
  27. Betourne, A., Szelechowski, M., Thouard, A., Abrial, E., Jean, A., Zaidi, F., Foret, C., Bonnaud, E. M., Charlier, C. M., Suberbielle, E., Malnou, C. E., Granon, S., Rampon, C. and Gonzalez-Dunia, D. (2018) Hippocampal expression of a virus-derived protein impairs memory in mice. Proc. Natl. Acad. Sci. U. S. A. 115, 1611-1616.
  28. Beurel, E., Toups, M. and Nemeroff, C. B. (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107, 234-256.
  29. Bhattacharya, A. and Jones, D. N. C. (2018) Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. Psychoneuroendocrinology 98, 95-100.
  30. Bhattacharya, A., Lord, B., Grigoleit, J. S., He, Y., Fraser, I., Campbell, S. N., Taylor, N., Aluisio, L., O'Connor, J. C., Papp, M., Chrovian, C., Carruthers, N., Lovenberg, T. W. and Letavic, M. A. (2018) Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia. Neuropsychopharmacology 43, 2586-2596.
  31. Bornand, D., Toovey, S., Jick, S. S. and Meier, C. R. (2016) The risk of new onset depression in association with influenza--a population-based observational study. Brain Behav. Immun. 53, 131-137.
  32. Buttiker, P., Stefano, G. B., Weissenberger, S., Ptacek, R., Anders, M., Raboch, J. and Kream, R. M. (2022) HIV, HSV, SARS-CoV-2 and Ebola share long-term neuropsychiatric sequelae. Neuropsychiatr. Dis. Treat. 18, 2229-2237.
  33. Bucci, M. (2015) Viral mechanisms: Tat modulates DAT. Nat. Chem. Biol. 11, 240.
  34. Burmeister, A. R., Gordevicius, J., Paul, E. N., Houck, C., George, S., Escobar Galvis, M. L., Sha, Q., Brundin, P., Pospisilik, J. A., Racicot, K. and Brundin, L. (2022) Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring. Neurobiol. Dis. 169, 105720.
  35. Cai, Q., Lan, K., Verma, S. C., Si, H., Lin, D. and Robertson, E. S. (2006) Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 80, 7965-7975.
  36. Cavalcante, G. I., Chaves Filho, A. J., Linhares, M. I., de Carvalho Lima, C. N., Venancio, E. T., Rios, E. R., de Souza, F. C., Vasconcelos, S. M., Macedo, D. and de Franca Fonteles, M. M. (2017) HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum. Eur. J. Pharmacol. 799, 7-15.
  37. Ceban, F., Nogo, D., Carvalho, I. P., Lee, Y., Nasri, F., Xiong, J., Lui, L. M. W., Subramaniapillai, M., Gill, H., Liu, R. N., Joseph, P., Teopiz, K. M., Cao, B., Mansur, R. B., Lin, K., Rosenblat, J. D., Ho, R. C. and McIntyre, R. S. (2021) Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA Psychiatry 78, 1079-1091.
  38. Chang, C. M., Hsieh, M. S., Yang, T. C., Hsieh, V. C., Chiang, J. H., Huang, H. H., How, C. K., Hu, S. Y. and Yen, D. H. (2017) Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients. Cancer Manag. Res. 9, 709-720.
  39. Chang, D., Dela Cruz, C. and Sharma, L. (2024) Beneficial and detrimental effects of cytokines during influenza and COVID-19. Viruses 16, 308.
  40. Chen, H. S., Wang, F. and Chen, J. G. (2024) Epigenetic mechanisms in depression: implications for pathogenesis and treatment. Curr. Opin. Neurobiol. 85, 102854.
  41. Chen, J. Y., Ren, Y., Yan, P., Belina, M. E., Chung, R. T. and Butt, A. A. (2018) Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: results from ERCHIVES. J. Viral. Hepat. 25, 825-833.
  42. Chen, M. H., Wei, H. T., Su, T. P., Li, C. T., Lin, W. C., Chang, W. H., Chen, T. J. and Bai, Y. M. (2014) Risk of depressive disorder among patients with herpes zoster: a nationwide population-based prospective study. Psychosom. Med. 76, 285-291.
  43. Chen, P. P., Wei, X. Y., Tao, L., Xin, X., Xiao, S. T. and He, N. (2023) Cerebral abnormalities in HIV-infected individuals with neurocognitive impairment revealed by fMRI. Sci. Rep. 13, 10331.
  44. Cheng, S., Wang, W., Zhu, Z., Zhao, M., Li, H., Liu, D. and Pan, F. (2023) Involvement of brain-derived neurotrophic factor methylation in the prefrontal cortex and hippocampus induced by chronic unpredictable mild stress in male mice. J. Neurochem. 164, 624-642.
  45. Cheng, S. W., Li, J. X., Chien, Y. C., Chang, J. P., Shityakov, S., Huang, S. Y., Galecki, P. and Su, K. P. (2021) Genetic variations of ionotropic glutamate receptor pathways on interferon-α-induced depression in patients with Hepatitis C viral infection. Brain Behav. Immun. 93, 16-22.
  46. Choi, H. G., Kim, E. J., Lee, Y. K. and Kim, M. (2019) The risk of herpes zoster virus infection in patients with depression: a longitudinal follow-up study using a national sample cohort. Medicine (Baltimore) 98, e17430.
  47. Cleaver, J., Jeffery, K., Klenerman, P., Lim, M., Handunnetthi, L., Irani, S. R. and Handel, A. (2024) The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain 147, 1130-1148.
  48. Collins, M. L., Cheney, G. A., Yehl, J. L., Sullivan, G. A., Stewart, J. T. and Catalano, G. (2021) Postviral depression. J. Psychiatr. Pract. 27, 126-130.
  49. COVID-19 Mental Disorders Collaborators (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398, 1700-1712.
  50. Cozzi, A., Zignego, A. L., Carpendo, R., Biagiotti, T., Aldinucci, A., Monti, M., Giannini, C., Rosselli, M., Laffi, G. and Moroni, F. (2006) Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J. Viral Hepat. 13, 402-408.
  51. Cymerys, J., Chodkowski, M., Slonska, A., Krzyzowska, M. and Banbura, M. W. (2019) Disturbances of mitochondrial dynamics in cultured neurons infected with human herpesvirus type 1 and type 2. J. Neurovirol. 25, 765-782.
  52. Dahm, T., Rudolph, H., Schwerk, C., Schroten, H. and Tenenbaum, T. (2016) Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm. 2016, 8562805.
  53. Dai, Y., Wei, T., Shen, Z., Bei, Y., Lin, H. and Dai, H. (2021) Classical HDACs in the regulation of neuroinflammation. Neurochem. Int. 150, 105182.
  54. Dalwadi, D. A., Ozuna, L., Harvey, B. H., Viljoen, M. and Schetz, J. A. (2018) Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs. Pharmacol. Rev. 70, 684-711.
  55. Danilenko, O. V., Gavrilova, N. Y. and Churilov, L. P. (2022) Chronic fatigue exhibits heterogeneous autoimmunity characteristics which reflect etiology. Pathophysiology 29, 187-199.
  56. Danilescu, C. M., Sandulescu, D. L., Pirlog, M. C., Streba, C. T. and Rogoveanu, I. (2021) Depressive and anxious symptoms in Hepatitis C virus infected patients receiving DAA-based therapy. Diagnostics (Basel) 11, 2237.
  57. Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A. and Yarchoan, R. (2001) Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 97, 3244-3250.
  58. De Francesco, M. A. (2024) Herpesviridae, neurodegenerative disorders and autoimmune diseases: what is the relationship between them? Viruses 16, 133.
  59. de Knegt, R. J., Bezemer, G., Van Gool, A. R., Drenth, J. P., Hansen, B. E., Droogleever Fortuyn, H. A., Weegink, C. J., Hengeveld, M. W. and Janssen, H. L. (2011) Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. Aliment. Pharmacol. Ther. 34, 1306-1317.
  60. Denton, A. R., Mactutus, C. F., Lateef, A. U., Harrod, S. B. and Booze, R. M. (2021) Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage. J. Neurovirol. 27, 403-421.
  61. Dietrich, D. E., Bode, L., Spannhuth, C. W., Hecker, H., Ludwig, H. and Emrich, H. M. (2020) Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial. BMC Pharmacol. Toxicol. 21, 12.
  62. Dollish, H. K., Tsyglakova, M. and McClung, C. A. (2024) Circadian rhythms and mood disorders: time to see the light. Neuron 112, 25-40.
  63. Dusedau, H. P., Steffen, J., Figueiredo, C. A., Boehme, J. D., Schultz, K., Erck, C., Korte, M., Faber-Zuschratter, H., Smalla, K. H., Dieterich, D., Kroger, A., Bruder, D. and Dunay, I. R. (2021) Influenza A virus (H1N1) infection induces microglial activation and temporal dysbalance in glutamatergic synaptic transmission. mBio 12, e0177621.
  64. Du, L., Fan, X., Yang, Y., Wu, S. and Liu, Y. (2024a) Quercetin ameliorates cognitive impairment in depression by targeting HSP90 to inhibit NLRP3 inflammasome activation. Mol. Neurobiol. 61, 6628-6641.
  65. Du, Y., Yan, T., Wu, B., He, B. and Jia, Y. (2024b) Research on the mechanism of antidepressive effect of Suanzaoren Decoction through TLR4/MyD88/NF-κB pathway and Wnt/β-catenin pathway. J. Ethnopharmacol. 319, 117190.
  66. Duarte, L. F., Farias, M. A., Alvarez, D. M., Bueno, S. M., Riedel, C. A. and Gonzalez, P. A. (2019) Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders. Front. Cell. Neurosci. 13, 46.
  67. Dwight, M. M., Kowdley, K. V., Russo, J. E., Ciechanowski, P. S., Larson, A. M. and Katon, W. J. (2000) Depression, fatigue, and functional disability in patients with chronic hepatitis C. J. Psychosom. Res. 49, 311-317.
  68. Ehret, M. and Sobieraj, D. M. (2014) Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int. J. Clin. Pract. 68, 255-261.
  69. el-Serag, H. B., Kunik, M., Richardson, P. and Rabeneck, L. (2002) Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 123, 476-482.
  70. Elliott, A. J., Russo, J., Bergam, K., Claypoole, K., Uldall, K. K. and Roy-Byrne, P. P. (1999) Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. J. Clin. Psychiatry 60, 226-231.
  71. Ellis, R. J., Fan, Y., Grelotti, D., Tang, B., Letendre, S. and He, J. J. (2022) Astrocyte activation is a potential mechanism underlying depressed mood and apathy in people with HIV. J. Neurol. Psychol. 9, 5.
  72. Ellis, R. J., Letendre, S. L., Atkinson, J. H., Clifford, D., Collier, A. C., Gelman, B. B., Marra, C., McCutchan, J. A., Morgello, S., Sacktor, N., Tang, B. and Heaton, R. K. (2020) Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV. Brain Behav. Immun. Health 7, 100121.
  73. Fabrazzo, M., Cipolla, S., Pisaturo, M., Camerlengo, A., Bucci, P., Pezzella, P., Coppola, N. and Galderisi, S. (2023) Bidirectional relationship between HIV/HBV infection and comorbid depression and/or anxiety: a systematic review on shared biological mechanisms. J. Pers. Med. 13, 1689.
  74. Fatma, N., Zakaria, S., Mourad, Z., Samir, B. and Samia, B. S. (2022) Atypical anti-NMDA receptor encephalitis associated with varicella zoster virus infection. J. Neurovirol. 28, 456-459.
  75. Fava, M. and Davidson, K. G. (1996) Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 19, 179-200.
  76. Fedotova, J. and Bereza, Z. (2022) SSRIs treatment did not completely restore affective state in patients with the initial clinically confirmed major depressive disorder/generalized anxiety disorder after COVID-19 disease. Eur. Psychiatry 65, S96.
  77. Feng, S., Liu, Y., Zhou, Y., Shu, Z., Cheng, Z., Brenner, C. and Feng, P. (2023) Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer's disease. Front. Aging Neurosci. 15, 1245904.
  78. Filgueira, L., Larionov, A. and Lannes, N. (2021) The influence of virus infection on microglia and accelerated brain aging. Cells 10, 1836.
  79. Firouzabadi, D., Kheshti, F., Abdollahifard, S., Taherifard, E. and Kheshti, M. R. (2022) The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: a systematic review and meta-analysis. Health Sci. Rep. 5, e892.
  80. Fischer, N. (2020) Infection-induced epigenetic changes and their impact on the pathogenesis of diseases. Semin. Immunopathol. 42, 127-130.
  81. Fletcher, N. F. and McKeating, J. A. (2012) Hepatitis C virus and the brain. J. Viral Hepat. 19, 301-306.
  82. Fletcher, N. F., Wilson, G. K., Murray, J., Hu, K., Lewis, A., Reynolds, G. M., Stamataki, Z., Meredith, L. W., Rowe, I. A., Luo, G., Lopez-Ramirez, M. A., Baumert, T. F., Weksler, B., Couraud, P. O., Kim, K. S., Romero, I. A., Jopling, C., Morgello, S., Balfe, P. and McKeating, J. A. (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142, 634-643.e6.
  83. Fond, G., Nemani, K., Etchecopar-Etchart, D., Loundou, A., Goff, D. C., Lee, S. W., Lancon, C., Auquier, P., Baumstarck, K., Llorca, P. M., Yon, D. K. and Boyer, L. (2021) Association between mental health disorders and mortality among patients With COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry 78, 1208-1217.
  84. Fontana, R. J., Hussain, K. B., Schwartz, S. M., Moyer, C. A., Su, L. and Lok, A. S. (2002) Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J. Hepatol. 36, 401-407.
  85. Ford, B. N. and Savitz, J. (2023) Effect of cytomegalovirus on the immune system: implications for aging and mental health. Curr. Top. Behav. Neurosci. 61, 181-214.
  86. Frye, M. A., Coombes, B. J., McElroy, S. L., Jones-Brando, L., Bond, D. J., Veldic, M., Romo-Nava, F., Bobo, W. V., Singh, B., Colby, C., Skime, M. K., Biernacka, J. M. and Yolken, R. (2019) Association of cytomegalovirus and Toxoplasma gondii antibody titers with bipolar disorder. JAMA Psychiatry 76, 1285-1293.
  87. Fu, R., Jinnah, H., McKay, J. L., Miller, A. H., Felger, J. C., Farber, E. W., Sharma, S., Whicker, N., Moore, R. C., Franklin, D., Letendre, S. L. and Anderson, A. M. (2023) Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression. J. Neurovirol. 29, 440-448.
  88. Gale, S. D., Berrett, A. N., Erickson, L. D., Brown, B. L. and Hedges, D. W. (2018) Association between virus exposure and depression in US adults. Psychiatry Res. 261, 73-79.
  89. Gebara, E., Zanoletti, O., Ghosal, S., Grosse, J., Schneider, B. L., Knott, G., Astori, S. and Sandi, C. (2021) Mitofusin-2 in the nucleus accumbens regulates anxiety and depression-like behaviors through mitochondrial and neuronal actions. Biol. Psychiatry 89, 1033-1044.
  90. Gelman, B. B., Lisinicchia, J. G., Chen, T., Johnson, K. M., Jennings, K., Freeman, D. H., Jr. and Soukup, V. M. (2012) Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J. Neuroimmune Pharmacol. 7, 686-700.
  91. Ghaffaripour Jahromi, G., Razi, S. and Rezaei, N. (2024) NLRP3 inflammatory pathway. Can we unlock depression? Brain Res. 1822, 148644.
  92. Gharbawy, D., Tadrous, M. and Suda, K. (2012) Does depression lead to influenza? - a systematic literature analysis. J. Affect. Disord. 138, 41-45.
  93. Ghassemi, S., Asgari, T., Mirzapour-Delavar, H., Aliakbari, S., Pourbadie, H. G., Prehaud, C., Lafon, M., Gholami, A., Azadmanesh, K., Naderi, N. and Sayyah, M. (2022) Lentiviral expression of rabies virus glycoprotein in the rat hippocampus strengthens synaptic plasticity. Cell. Mol. Neurobiol. 42, 1429-1440.
  94. Golden, S. A., Christoffel, D. J., Heshmati, M., Hodes, G. E., Magida, J., Davis, K., Cahill, M. E., Dias, C., Ribeiro, E., Ables, J. L., Kennedy, P. J., Robison, A. J., Gonzalez-Maeso, J., Neve, R. L., Turecki, G., Ghose, S., Tamminga, C. A. and Russo, S. J. (2013) Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat. Med. 19, 337-344.
  95. Gonzalez-Dunia, D., Volmer, R., Mayer, D. and Schwemmle, M. (2005) Borna disease virus interference with neuronal plasticity. Virus Res. 111, 224-234.
  96. Gosztonyi, G. and Ludwig, H. (2001) Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons. Curr. Top. Microbiol. Immunol. 253, 121-144.
  97. Greeson, J. M., Gettes, D. R., Spitsin, S., Dube, B., Benton, T. D., Lynch, K. G., Douglas, S. D. and Evans, D. L. (2016) The selective serotonin reuptake inhibitor citalopram decreases human immunodeficiency virus receptor and coreceptor expression in immune cells. Biol. Psychiatry 80, 33-39.
  98. Gutierrez, F., Garcia, L., Padilla, S., Alvarez, D., Moreno, S., Navarro, G., Gomez-Sirvent, J., Vidal, F., Asensi, V. and Masia, M. (2014) Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. HIV Med. 15, 213-223.
  99. Hacohen, Y., Deiva, K., Pettingill, P., Waters, P., Siddiqui, A., Chretien, P., Menson, E., Lin, J. P., Tardieu, M., Vincent, A. and Lim, M. J. (2014) N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov. Disord. 29, 90-96.
  100. Haeri, S., Johnson, N., Baker, A. M., Stuebe, A. M., Raines, C., Barrow, D. A. and Boggess, K. A. (2011) Maternal depression and Epstein-Barr virus reactivation in early pregnancy. Obstet. Gynecol. 117, 862-866.
  101. Han, Q., Li, W., Chen, P., Wang, L., Bao, X., Huang, R., Liu, G. and Chen, X. (2024) Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression. Neural Regen. Res. 19, 1890-1898.
  102. Heaton, N. S. and Randall, G. (2010) Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8, 422-432.
  103. Heeren, M., Sojref, F., Schuppner, R., Worthmann, H., Pflugrad, H., Tryc, A. B., Pasedag, T. and Weissenborn, K. (2014) Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infection. J. Hepatol. 60, 732-740.
  104. Hellmuth, J., Colby, D., Valcour, V., Suttichom, D., Spudich, S., Ananworanich, J., Prueksakaew, P., Sailasuta, N., Allen, I., Jagodzinski, L. L., Slike, B., Ochi, D. and Paul, R. (2017) Depression and anxiety are common in acute HIV infection and associate with plasma immune activation. AIDS Behav. 21, 3238-3246.
  105. Hickie, I., Bennett, B., Mitchell, P., Wilhelm, K. and Orlay, W. (1996) Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust. N. Z. J. Psychiatry 30, 246-252.
  106. Horowitz, T., Pellerin, L., Zimmer, E. and Guedj, E. (2023) Brain fog in long COVID: a glutamatergic hypothesis with astrocyte dysfunction accounting for brain PET glucose hypometabolism. Med. Hypotheses 180, 111186.
  107. Hosseini, S., Wilk, E., Michaelsen-Preusse, K., Gerhauser, I., Baumgartner, W., Geffers, R., Schughart, K. and Korte, M. (2018) Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function. J. Neurosci. 38, 3060-3080.
  108. Huang, W., Wu, X., Yao, Z., Gu, Y., Lai, X., Meng, L. and Peng, S. (2023) Investigating the relationship between hepatitis B virus infection and postpartum depression in Chinese women: a retrospective cohort study. Front. Public Health 11, 1214151.
  109. Huang, X., Liu, X. and Yu, Y. (2017) Depression and chronic liver diseases: are there shared underlying mechanisms? Front. Mol. Neurosci. 10, 134.
  110. Hukkanen, V., Broberg, E., Salmi, A. and Eralinna, J. P. (2002) Cytokines in experimental herpes simplex virus infection. Int. Rev. Immunol. 21, 355-371.
  111. Hunsberger, H. C., Wang, D., Petrisko, T. J., Alhowail, A., Setti, S. E., Suppiramaniam, V., Konat, G. W. and Reed, M. N. (2016) Peripherally restricted viral challenge elevates extracellular glutamate and enhances synaptic transmission in the hippocampus. J. Neurochem. 138, 307-316.
  112. Hwang, J. H., Lee, J. S., Oh, H. M., Lee, E. J., Lim, E. J. and Son, C. G. (2023) Evaluation of viral infection as an etiology of ME/CFS: a systematic review and meta-analysis. J. Transl. Med. 21, 763.
  113. Iosifescu, A. L., Hoogenboom, W. S., Buczek, A. J., Fleysher, R. and Duong, T. Q. (2022) New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: a retrospective cohort study in a large New York City healthcare network. Int. J. Methods Psychiatr. Res. 31, e1914.
  114. Irwin, M. R., Levin, M. J., Carrillo, C., Olmstead, R., Lucko, A., Lang, N., Caulfield, M. J., Weinberg, A., Chan, I. S., Clair, J., Smith, J. G., Marchese, R. D., Williams, H. M., Beck, D. J., McCook, P. T., Johnson, G. and Oxman, M. N. (2011) Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav. Immun. 25, 759-766.
  115. Islam, M. R., Sohan, M., Daria, S., Masud, A. A., Ahmed, M. U., Roy, A. and Shahriar, M. (2023) Evaluation of inflammatory cytokines in drug-naive major depressive disorder: a systematic review and meta-analysis. Int. J. Immunopathol. Pharmacol. 37, 3946320231198828.
  116. Jiang, J., Yang, M., Tian, M., Chen, Z., Xiao, L. and Gong, Y. (2023) Intertwined associations between oxytocin, immune system and major depressive disorder. Biomed. Pharmacother. 163, 114852.
  117. Jones-Brando, L., Dickerson, F., Ford, G., Stallings, C., Origoni, A., Katsafanas, E., Sweeney, K., Squire, A., Khushalani, S. and Yolken, R. (2020) Atypical immune response to Epstein-Barr virus in major depressive disorder. J. Affect. Disord. 264, 221-226.
  118. Kafali, H. Y., Dasgin, H., Sahin Cevik, D., Sozan, S. S., Oguz, K. K., Mutlu, M., Parlakay, A. O. and Toulopoulou, T. (2023) The effect of SARS-CoV-2 virus on resting-state functional connectivity during adolescence: investigating brain correlates of psychotic-like experiences and SARS-CoV-2 related inflammation response. Psychiatry Res. Neuroimaging 336, 111746.
  119. Kaharuza, F. M., Bunnell, R., Moss, S., Purcell, D. W., Bikaako-Kajura, W., Wamai, N., Downing, R., Solberg, P., Coutinho, A. and Mermin, J. (2006) Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 10, S105-S111.
  120. Kalkman, H. O. and Feuerbach, D. (2016) Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol. Ther. 163, 82-93.
  121. Kamyshna, I. I., Pavlovych, L. B. and Kamyshnyi, A. M. (2022) Association between NMDA gene polymorphism (rs4880213) and GRIN2B blood serum levels in thyroid pathology patients. J. Med. Life 15, 109-116.
  122. Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B. and Khandaker, G. M. (2018) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol. Psychiatry 23, 335-343.
  123. Karlovic, D., Serretti, A., Vrkic, N., Martinac, M. and Marcinko, D. (2012) Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res. 198, 74-80.
  124. Kelley, K. W. and Kent, S. (2020) The legacy of sickness behaviors. Front. Psychiatry 11, 607269.
  125. Kesby, J. P., Markou, A. and Semenova, S. (2016) Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice. Behav. Brain Res. 311, 131-140.
  126. Khalefah, M. M. and Khalifah, A. M. (2020) Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications. J. Taibah Univ. Med. Sci. 15, 550-553.
  127. Khan, M., Baussan, Y. and Hebert-Chatelain, E. (2023) Connecting dots between mitochondrial dysfunction and depression. Biomolecules 13, 695.
  128. Khan, N., Haughey, N. J., Nath, A. and Geiger, J. D. (2019) Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease. Brain Res. 1722, 146389.
  129. Khoodoruth, M. A. S., Estudillo-Guerra, M. A., Pacheco-Barrios, K., Nyundo, A., Chapa-Koloffon, G. and Ouanes, S. (2022) Glutamatergic system in depression and its role in neuromodulatory techniques optimization. Front. Psychiatry 13, 886918.
  130. Kimera, E., Vindevogel, S., Reynaert, D., Justice, K. M., Rubaihayo, J., De Maeyer, J., Engelen, A. M., Musanje, K. and Bilsen, J. (2020) Experiences and effects of HIV-related stigma among youth living with HIV/AIDS in Western Uganda: a photovoice study. PLoS One 15, e0232359.
  131. Kircheis, R. and Planz, O. (2023) The role of toll-like receptors (TLRs) and their related signaling pathways in viral infection and inflammation. Int. J. Mol. Sci. 24, 6701.
  132. Kjellman, B. F., Thorell, L. H., Orhagen, T., d'Elia, G. and Kagedal, B. (1993) The hypothalamic-pituitary-thyroid axis in depressive patients and healthy subjects in relation to the hypothalamic-pituitary-adrenal axis. Psychiatry Res. 47, 7-21.
  133. Klinedinst, N. J. and Regenold, W. T. (2015) A mitochondrial bioenergetic basis of depression. J. Bioenerg. Biomembr. 47, 155-171.
  134. Kobayashi, N., Oka, N., Takahashi, M., Shimada, K., Ishii, A., Tatebayashi, Y., Shigeta, M., Yanagisawa, H. and Kondo, K. (2020) Human herpesvirus 6B greatly increases risk of depression by activating hypothalamic-pituitary-adrenal axis during latent phase of infection. iScience 23, 101187.
  135. Kohler-Forsberg, O., Lydholm, C. N., Hjorthoj, C., Nordentoft, M., Mors, O. and Benros, M. E. (2019) Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr. Scand. 139, 404-419.
  136. Kohler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O. and Krogh, J. (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71, 1381-1391.
  137. Konsman, J. P. (2021) So many faces, phases, and facets, sickness behavior beyond disciplines. Front. Psychiatry 12, 630331.
  138. Kraus, R. J., Yu, X., Cordes, B. A., Sathiamoorthi, S., Iempridee, T., Nawandar, D. M., Ma, S., Romero-Masters, J. C., McChesney, K. G., Lin, Z., Makielski, K. R., Lee, D. L., Lambert, P. F., Johannsen, E. C., Kenney, S. C. and Mertz, J. E. (2017) Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathog. 13, e1006404.
  139. Krause, C., Bergmann, E. and Schmidt, S. V. (2024) Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection. Mol. Biol. Rep. 51, 342.
  140. Kucukkarapinar, M., Yay-Pence, A., Yildiz, Y., Buyukkoruk, M., YazAydin, G., Deveci-Bulut, T. S., Gulbahar, O., Senol, E. and Candansayar, S. (2022) Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. J. Neural Transm. (Vienna) 129, 1077-1089.
  141. Kwon, D. Y., Xu, B., Hu, P., Zhao, Y. T., Beagan, J. A., Nofziger, J. H., Cui, Y., Phillips-Cremins, J. E., Blendy, J. A., Wu, H. and Zhou, Z. (2022) Neuronal Yin Yang1 in the prefrontal cortex regulates transcriptional and behavioral responses to chronic stress in mice. Nat. Commun. 13, 55.
  142. Lai, J. Y., Ho, J. X., Kow, A. S. F., Liang, G., Tham, C. L., Ho, Y. C. and Lee, M. T. (2023) Interferon therapy and its association with depressive disorders - a review. Front. Immunol. 14, 1048592.
  143. Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. and Penninx, B. W. (2013) Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18, 692-699.
  144. Lee, S., Ha, H., Jang, J. and Byun, Y. (2023) Recent advances in the development of antidepressants targeting the purinergic P2X7 receptor. Curr. Med. Chem. 30, 164-177.
  145. Lefkowitz, R. B., Miller, C. M., Martinez-Caballero, J. D. and Ramos, I. (2024) Epigenetic control of innate immunity: consequences of acute respiratory virus infection. Viruses 16, 197.
  146. Leng, A., Shah, M., Ahmad, S. A., Premraj, L., Wildi, K., Li Bassi, G., Pardo, C. A., Choi, A. and Cho, S. M. (2023) Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12, 816.
  147. Leung, C. M. C., Ho, M. K., Bharwani, A. A., Cogo-Moreira, H., Wang, Y., Chow, M. S. C., Fan, X., Galea, S., Leung, G. M. and Ni, M. Y. (2022) Mental disorders following COVID-19 and other epidemics: a systematic review and meta-analysis. Transl. Psychiatry 12, 205.
  148. Li, C. W., Chen, Y. C., Lee, N. Y., Chen, P. L., Li, M. C., Li, C. Y., Ko, W. C. and Ko, N. Y. (2021a) Efavirenz is not associated with an increased risk of depressive disorders in patients living with HIV: an 11-year population-based study in Taiwan. Healthcare (Basel) 9, 1625.
  149. Li, H., Zhu, W., Zhang, L., Lei, H., Wu, X., Guo, L., Chen, X., Wang, Y. and Tang, H. (2015) The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci. Rep. 5, 8421.
  150. Li, S., Ma, F., Yokota, T., Garcia, G., Jr., Palermo, A., Wang, Y., Farrell, C., Wang, Y. C., Wu, R., Zhou, Z., Pan, C., Morselli, M., Teitell, M. A., Ryazantsev, S., Fishbein, G. A., Hoeve, J. T., Arboleda, V. A., Bloom, J., Dillon, B., Pellegrini, M., Lusis, A. J., Graeber, T. G., Arumugaswami, V. and Deb, A. (2021b) Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. JCI Insight 6, e145027.
  151. Li Puma, D. D., Colussi, C., Bandiera, B., Puliatti, G., Rinaudo, M., Cocco, S., Paciello, F., Re, A., Ripoli, C., De Chiara, G., Bertozzi, A., Palamara, A. T., Piacentini, R. and Grassi, C. (2023) Interleukin 1β triggers synaptic and memory deficits in Herpes simplex virus type-1-infected mice by downregulating the expression of synaptic plasticity-related genes via the epigenetic MeCP2/HDAC4 complex. Cell. Mol. Life Sci. 80, 172.
  152. Liao, C. H., Chang, C. S., Muo, C. H. and Kao, C. H. (2015) High prevalence of herpes zoster in patients with depression. J. Clin. Psychiatry 76, e1099-e1104.
  153. Lier, J., Stoll, K., Obrig, H., Baum, P., Deterding, L., Bernsdorff, N., Hermsdorf, F., Kunis, I., Brasecke, A., Herzig, S., Schroeter, M. L., Thone-Otto, A., Riedel-Heller, S. G., Laufs, U., Wirtz, H., Classen, J. and Saur, D. (2022) Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients. Front. Neurol. 13, 988359.
  154. Limanaqi, F., Zecchini, S., Dino, B., Strizzi, S., Cappelletti, G., Utyro, O., Vanetti, C., Garziano, M., Saulle, I., Clerici, M. and Biasin, M. (2022) Dopamine reduces SARS-CoV-2 replication in vitro through downregulation of D2 receptors and upregulation of type-I interferons. Cells 11, 1691.
  155. Lisnasari, B., Ardianto, C. and Khotib, J. (2022) Microglia as a potential target for antidepressant: a systematic review on preclinical studies. RJPT 15, 3317-3323.
  156. Liu, Q., Zhang, M. M., Guo, M. X., Zhang, Q. P., Li, N. Z., Cheng, J., Wang, S. L., Xu, G. H., Li, C. F., Zhu, J. X. and Yi, L. T. (2022a) Inhibition of microglial NLRP3 with MCC950 attenuates microglial morphology and NLRP3/caspase-1/IL-1β signaling in stress-induced mice. J. Neuroimmune Pharmacol. 17, 503-514.
  157. Liu, Y., Hu, P., Zheng, Z., Zhong, D., Xie, W., Tang, Z., Pan, B., Luo, J., Zhang, W. and Wang, X. (2022b) Photoresponsive vaccine-like CAR-M system with high-efficiency central immune regulation for inflammation-related depression. Adv. Mater 34, e2108525.
  158. Locatelli, M. and Faure-Dupuy, S. (2023) Virus hijacking of host epigenetic machinery to impair immune response. J. Virol. 97, e0065823.
  159. Lorkiewicz, P. and Waszkiewicz, N. (2021) Biomarkers of post-COVID depression. J. Clin. Med. 10, 4142.
  160. Louie, A. Y., Kim, J. S., Drnevich, J., Dibaeinia, P., Koito, H., Sinha, S., McKim, D. B., Soto-Diaz, K., Nowak, R. A., Das, A. and Steelman, A. J. (2023) Influenza A virus infection disrupts oligodendrocyte homeostasis and alters the myelin lipidome in the adult mouse. J. Neuroinflammation 20, 190.
  161. Low-Beer, S., Chan, K., Yip, B., Wood, E., Montaner, J. S., O'Shaughnessy, M. V. and Hogg, R. S. (2000) Depressive symptoms decline among persons on HIV protease inhibitors. J. Acquir. Immune Defic. Syndr. 23, 295-301.
  162. Lu, H., Surkan, P. J., Irwin, M. R., Treisman, G. J., Breen, E. C., Sacktor, N., Stall, R., Wolinsky, S. M., Jacobson, L. P. and Abraham, A. G. (2019) Inflammation and risk of depression in HIV: prospective findings from the multicenter AIDS cohort study. Am. J. Epidemiol. 188, 1994-2003.
  163. Lu, J., Liang, J., Yang, J., Mischoulon, D. and Nyer, M. (2023) Does the association between Herpes Simplex 2 infection and depressive symptoms vary among different sexual minority statuses and sex groups? Findings from a nationally representative sample. J. Affect. Disord. 327, 226-229.
  164. Lu, Y., Liu, B. P., Tan, C. T., Pan, F., Larbi, A. and Ng, T. P. (2022) Lifetime pathogen burden, inflammatory markers, and depression in community-dwelling older adults. Brain Behav. Immun. 102, 124-134.
  165. Lyu, D., Wang, F., Zhang, M., Yang, W., Huang, H., Huang, Q., Wu, C., Qian, N., Wang, M., Zhang, H., Zheng, S., Chen, J., Fu, Y., Zhang, C., Li, Z. and Hong, W. (2022) Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway. Psychopharmacology (Berl.) 239, 3201-3212.
  166. Ma, L., Wang, F., Li, Y., Wang, J., Chang, Q., Du, Y., Sadan, J., Zhao, Z., Fan, G., Yao, B. and Chen, J. F. (2023) Brain methylome remodeling selectively regulates neuronal activity genes linking to emotional behaviors in mice exposed to maternal immune activation. Nat. Commun. 14, 7829.
  167. Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Galecki, P. and Leonard, B. (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 10, 66.
  168. Maier, H. B., Neyazi, A., Bundies, G. L., Meyer-Bockenkamp, F., Bleich, S., Pathak, H., Ziert, Y., Neuhaus, B., Muller, F. J., Pollmann, I., Illig, T., Mucke, S., Muller, M., Moller, B. K., Oeltze-Jafra, S., Kacprowski, T., Voges, J., Muntefering, F., Scheiber, J., Reif, A., Aichholzer, M., Reif-Leonhard, C., Schmidt-Kassow, M., Hegerl, U., Reich, H., Unterecker, S., Weber, H., Deckert, J., Bossel-Debbert, N., Grabe, H. J., Lucht, M. and Frieling, H. (2024) Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trial. Trials 25, 247.
  169. Mangold, C. A. and Szpara, M. L. (2019) Persistent infection with herpes simplex virus 1 and Alzheimer's disease-a call to study how variability in both virus and host may impact disease. Viruses 11, 966.
  170. Marathe, G., Moodie, E. E. M., Brouillette, M. J., Laniece Delaunay, C., Cox, J., Martel-Laferriere, V., Gill, J., Cooper, C., Pick, N., Vachon, M. L., Walmsley, S. and Klein, M. B. (2023) Impact of hepatitis C virus cure on depressive symptoms in the human immunodeficiency virus-hepatitis C virus coinfected population in Canada. Clin. Infect. Dis. 76, e702-e709.
  171. Markkula, N., Lindgren, M., Yolken, R. H. and Suvisaari, J. (2020) Association of exposure to Toxoplasma gondii, Epstein-Barr Virus, Herpes Simplex virus Type 1 and Cytomegalovirus with new-onset depressive and anxiety disorders: an 11-year follow-up study. Brain Behav. Immun. 87, 238-242.
  172. Mattson, M. P., Gleichmann, M. and Cheng, A. (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748-766.
  173. Maurya, S. K., Baghel, M. S., Gaurav, Chaudhary, V., Kaushik, A. and Gautam, A. (2022) Putative role of mitochondria in SARS-CoV-2 mediated brain dysfunctions: a prospect. Biotechnol. Genet. Eng. Rev. 39, 167-192.
  174. Maximova, O. A., Sturdevant, D. E., Kash, J. C., Kanakabandi, K., Xiao, Y., Minai, M., Moore, I. N., Taubenberger, J., Martens, C., Cohen, J. I. and Pletnev, A. G. (2021) Virus infection of the CNS disrupts the immune-neural-synaptic axis via induction of pleiotropic gene regulation of host responses. Elife 10, e62273.
  175. Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P. and Benedetti, F. (2022) Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur. Neuropsychopharmacol. 54, 1-6.
  176. McFadden, K., Hafez, A. Y., Kishton, R., Messinger, J. E., Nikitin, P. A., Rathmell, J. C. and Luftig, M. A. (2016) Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization. Proc. Natl. Acad. Sci. U. S. A. 113, E782-E790.
  177. McLaurin, K. A., Harris, M., Madormo, V., Harrod, S. B., Mactutus, C. F. and Booze, R. M. (2021) HIV-associated apathy/depression and neurocognitive impairments reflect persistent dopamine deficits. Cells 10, 2158.
  178. Meng, Y., Du, J., Liu, N., Qiang, Y., Xiao, L., Lan, X., Ma, L., Yang, J., Yu, J. and Lu, G. (2023) Epigenetic modulation: research progress on histone acetylation levels in major depressive disorders. J. Drug Target. 31, 142-151.
  179. Menke, A. (2024) The HPA axis as target for depression. Curr. Neuropharmacol. 22, 904-915.
  180. Mertowska, P., Smolak, K., Mertowski, S. and Grywalska, E. (2023) Immunomodulatory role of interferons in viral and bacterial infections. Int. J. Mol. Sci. 24, 10115.
  181. Merz, M. P., Seal, S. V., Grova, N., Meriaux, S., Guebels, P., Kanli, G., Mommaerts, E., Nicot, N., Kaoma, T., Keunen, O., Nazarov, P. V. and Turner, J. D. (2024) Early-life influenza A (H1N1) infection independently programs brain connectivity, HPA AXIS and tissue-specific gene expression profiles. Sci. Rep. 14, 5898.
  182. Midde, N. M., Gomez, A. M. and Zhu, J. (2012) HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J. Neuroimmune Pharmacol. 7, 629-639.
  183. Miguez-Burbano, M. J., Rodriguez, A., Vargas, M., Tantalean, G., Valiathan, R. and Chan, W. (2014) Are serotonin alterations the link between thrombocytopenia and poor immune status among HIV infected individuals? J. AIDS Clin. Res. 2, 1000277.
  184. Mihaescu, G., Chifiriuc, M. C., Filip, R., Bleotu, C., Ditu, L. M., Constantin, M., Cristian, R. E., Grigore, R., Bertesteanu, S. V., Bertesteanu, G. and Vrancianu, C. O. (2023) Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection. Front. Immunol. 14, 1273604.
  185. Miller, G. E., Freedland, K. E., Duntley, S. and Carney, R. M. (2005) Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am. J. Cardiol. 95, 317-321.
  186. Min, X., Wang, G., Cui, Y., Meng, P., Hu, X., Liu, S. and Wang, Y. (2023) Association between inflammatory cytokines and symptoms of major depressive disorder in adults. Front. Immunol. 14, 1110775.
  187. Misztak, P., Panczyszyn-Trzewik, P. and Sowa-Kucma, M. (2018) Histone deacetylases (HDACs) as therapeutic target for depressive disorders. Pharmacol. Rep. 70, 398-408.
  188. Mocchetti, I., Bachis, A., Campbell, L. A. and Avdoshina, V. (2014) Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors. J. Neuroimmune Pharmacol. 9, 80-91.
  189. Mohammad, S. S., Sinclair, K., Pillai, S., Merheb, V., Aumann, T. D., Gill, D., Dale, R. C. and Brilot, F. (2014) Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov. Disord. 29, 117-122.
  190. Moreno, J. L., Kurita, M., Holloway, T., Lopez, J., Cadagan, R., Martinez-Sobrido, L., Garcia-Sastre, A. and Gonzalez-Maeso, J. (2011) Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT2A and mGlu2 receptors in the adult offspring. J. Neurosci. 31, 1863-1872.
  191. Mori, I., Imai, Y., Kohsaka, S. and Kimura, Y. (2000) Upregulated expression of Iba1 molecules in the central nervous system of mice in response to neurovirulent influenza A virus infection. Microbiol. Immunol. 44, 729-735.
  192. Mori, I. and Kimura, Y. (2001) Neuropathogenesis of influenza virus infection in mice. Microbes Infect. 3, 475-479.
  193. Morin, C. M., Vezina-Im, L. A., Ivers, H., Micoulaud-Franchi, J. A., Philip, P., Lamy, M. and Savard. J. (2022) Prevalent, incident, and persistent insomnia in a population-based cohort tested before (2018) and during the first-wave of COVID-19 pandemic (2020). Sleep 45, zsab258.
  194. Motta, C. S., Torices, S., da Rosa, B. G., Marcos, A. C., Alvarez-Rosa, L., Siqueira, M., Moreno-Rodriguez, T., Matos, A. D. R., Caetano, B. C., Martins, J., Gladulich, L., Loiola, E., Bagshaw, O. R. M., Stuart, J. A., Siqueira, M. M., Stipursky, J., Toborek, M. and Adesse, D. (2023) Human brain microvascular endothelial cells exposure to SARS-CoV-2 leads to inflammatory activation through NF-κB noncanonical pathway and mitochondrial remodeling. Viruses 15, 745.
  195. Muller, A. C. and Daya, S. (2008) Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5-hydroxyindole acetic acid levels. Metab. Brain Dis. 23, 351-360.
  196. Mudra Rakshasa-Loots, A., Bakewell, N., Sharp, D. J., Gisslen, M., Zetterberg, H., Alagaratnam, J., Wit, F., Kootstra, N. A., Winston, A., Reiss, P., Sabin, C. A. and Vera, J. H. (2023) Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms. Transl. Psychiatry 13, 190.
  197. Munshi, S., Alarbi, A. M., Zheng, H., Kuplicki, R., Burrows, K., Figueroa-Hall, L. K., Victor, T. A., Aupperle, R. L., Khalsa, S. S., Paulus, M. P., Teague, T. K. and Savitz, J. (2024) Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder. Mol. Psychiatry doi: 10.1038/s41380-024-02695-2 [Online ahead of print].
  198. Nakhaee, H., Zangiabadian, M., Bayati, R., Rahmanian, M., Ghaffari Jolfayi, A. and Rakhshanderou, S. (2022) The effect of antidepressants on the severity of COVID-19 in hospitalized patients: a systematic review and meta-analysis. PLoS One 17, e0267423.
  199. Nami, M., Mehrabi, S., Kamali, A. M., Kazemiha, M., Carvalho, J., Derman, S., Lakey-Betia, J., Vasquez, V. and Kosagisharaf, R. (2020) A new hypothesis on anxiety, sleep insufficiency, and viral infections; reciprocal links to consider in today's "World vs. COVID-19" endeavors. Front. Psychiatry 11, 585893.
  200. Narasimhappa, K., Mamtani, H., Jain, K., Holla, V. V., Ganjekar, S., Manjunath, N., Kulanthaivelu, K. and Desai, G. (2024) Unmasking bipolarity in recurrent depressive disorder following herpes simplex virus triggered n-methyl-D-aspartate encephalitis. Bipolar. Disord. 26, 192-195.
  201. Nataf, S. (2020) An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J. Med. Virol. 92, 1743-1744.
  202. Nataf, S. and Pays, L. (2021) Molecular insights into SARS-CoV2-induced alterations of the gut/brain axis. Int. J. Mol. Sci. 22, 10440.
  203. Nosadini, M., Mohammad, S. S., Corazza, F., Ruga, E. M., Kothur, K., Perilongo, G., Frigo, A. C., Toldo, I., Dale, R. C. and Sartori, S. (2017) Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev. Med. Child Neurol. 59, 796-805.
  204. Ohkawara, T., Katsuyama, T., Ida-Eto, M., Narita, N. and Narita, M. (2015) Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons. Brain Dev. 37, 88-93.
  205. Oriolo, G., Blanco-Hinojo, L., Navines, R., Marino, Z., Martin-Hernandez, D., Cavero, M., Gimenez, D., Caso, J., Capuron, L., Forns, X., Pujol, J., Sola, R. and Martin-Santos, R. (2019) Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patients. Brain Behav. Immun. 80, 204-218.
  206. Osei, D., Baumgart-Vogt, E., Ahlemeyer, B. and Herden, C. (2024) Tumor necrosis factor-α receptor 1 mediates Borna disease virus 1-induced changes in peroxisomal and mitochondrial dynamics in neurons. Int. J. Mol. Sci. 25, 1849.
  207. Pender, M. P. (2020) Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy. Clin. Transl. Immunology 9, e1116.
  208. Peron, J. P. S. (2023) Direct and indirect impact of SARS-CoV-2 on the brain. Hum. Genet. 142, 1317-1326.
  209. Philippi, C. L., Reyna, L., Nedderman, L., Chan, P., Samboju, V., Chang, K., Phanuphak, N., Ratnaratorn, N., Hellmuth, J., Benjapornpong, K., Dumrongpisutikul, N., Pothisri, M., Robb, M. L., Ananworanich, J., Spudich, S., Valcour, V. and Paul, R. (2020) Resting-state neural signatures of depressive symptoms in acute HIV. J. Neurovirol. 26, 226-240.
  210. Phillips, A. C., Carroll, D., Khan, N. and Moss, P. (2008) Cytomegalovirus is associated with depression and anxiety in older adults. Brain Behav. Immun. 22, 52-55.
  211. Piacentini, R., Li Puma, D. D., Ripoli, C., Marcocci, M. E., De Chiara, G., Garaci, E., Palamara, A. T. and Grassi, C. (2015) Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation. Sci. Rep. 5, 15444.
  212. Pinto, E. F. and Andrade, C. (2016) Interferon-related depression: a primer on mechanisms, treatment, and prevention of a common clinical problem. Curr. Neuropharmacol. 14, 743-748.
  213. Pratt, L. A., Xu, F., McQuillan, G. M. and Robitz, R. (2012) The association of depression, risky sexual behaviours and herpes simplex virus type 2 in adults in NHANES, 2005-2008. Sex. Transm. Infect. 88, 40-44.
  214. Premachandra, B. N., Kabir, M. A. and Williams, I. K. (2006) Low T3 syndrome in psychiatric depression. J. Endocrinol. Invest. 29, 568-572.
  215. Premraj, L., Kannapadi, N. V., Briggs, J., Seal, S. M., Battaglini, D., Fanning, J., Suen, J., Robba, C., Fraser, J. and Cho, S. M. (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 434, 120162.
  216. Pruss, H., Finke, C., Holtje, M., Hofmann, J., Klingbeil, C., Probst, C., Borowski, K., Ahnert-Hilger, G., Harms, L., Schwab, J. M., Ploner, C. J., Komorowski, L., Stoecker, W., Dalmau, J. and Wandinger, K. P. (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann. Neurol. 72, 902-911.
  217. Rademacher, L., Lasselin, J., Karshikoff, B., Hundt, J. E., Engler, H. and Lange, T. (2021) Editorial: the different faces of sickness. Front. Psychiatry 12, 735337.
  218. Raison, C. L. (2017) The promise and limitations of anti-inflammatory agents for the treatment of major depressive disorder. Curr. Top. Behav. Neurosci. 31, 287-302.
  219. Ranger, T. A., Clift, A. K., Patone, M., Coupland, C. A. C., Hatch, R., Thomas, K., Watkinson, P. and Hippisley-Cox, J. (2023) Preexisting neuropsychiatric conditions and associated risk of severe COVID-19 infection and other acute respiratory infections. JAMA Psychiatry 80, 57-65.
  220. Rappeneau, V., Wilmes, L. and Touma, C. (2020) Molecular correlates of mitochondrial dysfunctions in major depression: evidence from clinical and rodent studies. Mol. Cell. Neurosci. 109, 103555.
  221. Rasmi, Y., Shokati, A., Hatamkhani, S., Farnamian, Y., Naderi, R. and Jalali, L. (2024) Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID-19 infection. Rev. Med. Virol. 34, e2506.
  222. Rezaei, S., Ahmadi, S., Rahmati, J., Hosseinifard, H., Dehnad, A., Aryankhesal, A., Shabaninejad, H., Ghasemyani, S., Alihosseini, S., Bragazzi, N. L., Raoofi, S., Kiaee, Z. M. and Ghashghaee, A. (2019) Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support. Palliat. Care 9, 404-412.
  223. Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G. and Joca, S. (2019) P2X7 receptor signaling in stress and depression. Int. J. Mol. Sci. 20, 2778.
  224. Righetto, I., Gasparotto, M., Casalino, L., Vacca, M., Filippini, F. (2023) Exogenous players in mitochondria-related CNS disorders: viral pathogens and unbalanced microbiota in the gut-brain axis. Biomolecules 13, 169.
  225. Ru, W. and Tang, S. J. (2017) HIV-associated synaptic degeneration. Mol. Brain 10, 40.
  226. Rus, C. P., de Vries, B. E. K., de Vries, I. E. J., Nutma, I. and Kooij, J. J. S. (2023) Treatment of 95 post-Covid patients with SSRIs. Sci. Rep. 13, 18599.
  227. Sadasivan, S., Zanin, M., O'Brien, K., Schultz-Cherry, S. and Smeyne, R. J. (2015) Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus. PLoS One 10, e0124047.
  228. Sagar, V., Atluri, V. S., Pilakka-Kanthikeel, S. and Nair, M. (2016) Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse. Mol. Brain 9, 57.
  229. Saloner, R., Cherner, M., Grelotti, D. J., Paolillo, E. W., Moore, D. J., Heaton, R. K., Letendre, S. L., Kumar, A., Grant, I. and Ellis, R. J. (2020) Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease. Brain Behav. Immun. 90, 353-363.
  230. Sardar, A. M., Czudek, C. and Reynolds, G. P. (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7, 910-912.
  231. Sarkar, S., Kemper, J., Sarkar, R., Brants, L., Friebe, A., Spengler, U., Schlapfer, T., Reimer, J., Buggisch, P., Ockenga, J., Link, R., Rentrop, M., Weidenbach, H., Fromm, G., Lieb, K., Baumert, T. F., Discher, T., Zeuzem, S., Berg, T. and Schaefer, M. (2021) Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression. J. Affect. Disord. 292, 766-772.
  232. Schou, T. M., Joca, S., Wegener, G. and Bay-Richter, C. (2021) Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review. Brain Behav. Immun. 97, 328-348.
  233. Seegal, R. F. and McFarland, D. J. (1988) Stereotaxic microinjection of HSV-1 selectively decreases striatal dopamine concentrations in mice. Brain Res. 445, 234-240.
  234. Shah, S., Sinharay, S., Matsuda, K., Schreiber-Stainthorp, W., Muthusamy, S., Lee, D., Wakim, P., Hirsch, V., Nath, A., Di Mascio, M. and Hammoud, D. A. (2019) Potential mechanism for HIV-associated depression: upregulation of serotonin transporters in SIVinfected macaques detected by 11C-DASB PET. Front. Psychiatry 10, 362.
  235. Shaheen, A. A., Kaplan, G. G., Sharkey, K. A., Lethebe, B. C. and Swain, M. G. (2023) Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study. Hepatol. Commun. 7, e0062.
  236. Shi, Y., Wang, Q., Song, R., Kong, Y. and Zhang, Z. (2021) Non-coding RNAs in depression: promising diagnostic and therapeutic biomarkers. EBioMedicine 71, 103569.
  237. Shi, Y., Yang, C., Xu, L., He, Y., Wang, H., Cao, J., Wen, M., Chen, W., Wu, B., Chen, S. and Chen, H. (2020) CD4+ T cell count, sleep, depression, and anxiety in people living with HIV: a growth curve mixture modeling. J. Assoc. Nurses AIDS Care 31, 535-543.
  238. Shirayama, Y., Iwata, M., Miyano, K., Hirose, Y., Oda, Y., Fujita, Y. and Hashimoto, K. (2023) Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability. Brain Res. 1821, 148567.
  239. Shu, C., Jaffe, A. E., Sabunciyan, S., Ji, H., Astemborski, J., Sun, J., Bakulski, K. M., Mehta, S. H., Kirk, G. D. and Maher, B. S. (2020) Epigenome-wide association scan identifies methylation sites associated with HIV infection. Epigenomics 12, 1917-1927.
  240. Silva, C., Fonseca, C., Ferreira, R., Weidner, A., Morgado, B., Lopes, M. J., Moritz, S., Jelinek, L., Schneider, B. C. and Pinho, L. G. (2023) Depression in older adults during the COVID-19 pandemic: a systematic review. J. Am. Geriatr. Soc. 71, 2308-2325.
  241. Silvers, J. M., Aksenov, M. Y., Aksenova, M. V., Beckley, J., Olton, P., Mactutus, C. F. and Booze, R. M. (2006) Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. J. Neurovirol. 12, 140-145.
  242. Simoes, J. L. B., Galvan, A. C. L., da Silva, E. L. M., Ignacio, Z. M. and Bagatini, M. D. (2023) Therapeutic potential of the purinergic system in major depressive disorder associated with COVID-19. Cell. Mol. Neurobiol. 43, 621-637.
  243. Simanek, A. M., Cheng, C., Yolken, R., Uddin, M., Galea, S. and Aiello, A. E. (2014) Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology 50, 139-148.
  244. Simanek, A. M., Zheng, C., Yolken, R., Haan, M. and Aiello, A. E. (2019) A longitudinal study of the association between persistent pathogens and incident depression among older U.S. Latinos. J. Gerontol. A Biol. Sci. Med. Sci. 74, 634-641.
  245. Sinanan, K. and Hillary, I. (1981) Post-influenzal depression. Br. J. Psychiatry 138, 131-133.
  246. Slavuljica, I., Kvestak, D., Huszthy, P. C., Kosmac, K., Britt, W. J. and Jonjic, S. (2015) Immunobiology of congenital cytomegalovirus infection of the central nervous system-the murine cytomegalovirus model. Cell. Mol. Immunol. 12, 180-191.
  247. Solis, N., Salazar, L. and Hasbun, R. (2016) Anti-NMDA receptor antibody encephalitis with concomitant detection of Varicella zoster virus. J. Clin. Virol. 83, 26-28.
  248. Souery, D. (2023) Treatment-resistant depression: where to find hope? World Psychiatry 22, 422-423.
  249. Souery, D., Papakostas, G. I. and Trivedi, M. H. (2006) Treatment-resistant depression. J. Clin. Psychiatry 67 Suppl 6, 16-22.
  250. Starace, F., Bartoli, L., Aloisi, M. S., Antinori, A., Narciso, P., Ippolito, G., Ravasio, L., Moioli, M. C., Vangi, D., Gennero, L., Coronado, O. V., Giacometti, A., Nappa, S., Perulli, M. L., Montesarchio, V., La Gala, A., Ricci, F., Cristiano, L., De Marco, M., Izzo, C., Pezzotti, P. and D'Arminio Monforte, A. (2002) Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr. Scand. 106, 20-26.
  251. Stefano, G. B., Buttiker, P., Weissenberger, S., Ptacek, R., Wang, F., Esch, T., Bilfinger, T. V., Raboch, J. and Kream, R. M. (2022) Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID-19. Curr. Neuropharmacol. 20, 1229-1240.
  252. Sut, B. B. (2021) Epigenetic Regulation Mechanisms in Viral Infections: a Special Focus on COVID-19. IntechOpen, London.
  253. Strauss, M., O'Donovan, B., Ma, Y., Xiao, Z., Lin, S., Bardo, M. T., Ortinski, P. I., McLaughlin, J. P. and Zhu, J. (2020) [(3)H]dopamine uptake through the dopamine and norepinephrine transporters is decreased in the prefrontal cortex of transgenic mice expressing HIV-1 transactivator of transcription protein. J. Pharmacol. Exp. Ther. 374, 241-251.
  254. Su, K. P., Lai, H. C., Peng, C. Y., Su, W. P., Chang, J. P. and Pariante, C. M. (2019) Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder. Brain Behav. Immun. 80, 512-518.
  255. Su, W. J., Li, J. M., Zhang, T., Cao, Z. Y., Hu, T., Zhong, S. Y., Xu, Z. Y., Gong, H., Jiang, C. L. (2023) Microglial NLRP3 inflammasome activation mediates diabetes-induced depression-like behavior via triggering neuroinflammation. Prog. Neuropsychopharmacol. Biol. Psychiatry 126, 110796.
  256. Surendran, H., Kumar, S., Narasimhaiah, S., Ananthamurthy, A., Varghese, P. S., D'Souza, G. A., Medigeshi, G. and Pal, R. (2022) SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways. J. Cell. Physiol. 237, 2913-2928.
  257. Tabano, S., Tassi, L., Cannone, M. G., Brescia, G., Gaudioso, G., Ferrara, M., Colapietro, P., Fontana, L., Miozzo, M. R., Croci, G. A., Seia, M., Piuma, C., Solbiati, M., Tobaldini, E., Ferrero, S., Montano, N., Costantino, G. and Buoli, M. (2023) Mental health and the effects on methylation of stress-related genes in front-line versus other health care professionals during the second wave of COVID-19 pandemic: an Italian pilot study. Eur. Arch. Psychiatry Clin. Neurosci. 273, 347-356.
  258. Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q. and Harrison, P. J. (2022) Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 9, 815-827.
  259. Teng, C. F., Wu, H. C., Hsieh, W. C., Tsai, H. W. and Su, I. J. (2015) Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis. J. Virol. 89, 605-614.
  260. Teodorof-Diedrich, C. and Spector, S. A. (2018) Human immunodeficiency virus type 1 gp120 and Tat induce mitochondrial fragmentation and incomplete mitophagy in human neurons. J. Virol. 92, e00993.
  261. Tereshin, A. E., Kiryanova, V. V. and Reshetnik, D. A. (2022) Correction of mitochondrial dysfunction in the complex rehabilitation of COVID-19 patients. Neurosci. Behav. Physiol. 52, 511-514.
  262. Tesfaw, G., Ayano, G., Awoke, T., Assefa, D., Birhanu, Z., Miheretie, G. and Abebe, G. (2016) Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia. BMC Psychiatry 16, 368.
  263. Thai, M., Graham, N. A., Braas, D., Nehil, M., Komisopoulou, E., Kurdistani, S. K., McCormick, F., Graeber, T. G. and Christofk, H. R. (2014) Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab. 19, 694-701.
  264. Thaker, S. K., Ch'ng, J. and Christofk, H. R. (2019) Viral hijacking of cellular metabolism. BMC Biol. 17, 59.
  265. Thomas, P., Bhatia, T., Gauba, D., Wood, J., Long, C., Prasad, K., Dickerson, F. B., Gur, R. E., Gur, R. C., Yolken, R. H., Nimgaonkar, V. L. and Deshpande, S. N. (2013) Exposure to herpes simplex virus, type 1 and reduced cognitive function. J. Psychiatr. Res. 47, 1680-1685.
  266. Tsai, M. K., Sytwu, H. K., Hsieh, T. Y., Chien, W. C., Lai, C. H. and Chen, H. C. (2022) Association between depression or anxiety and the risk of hepatitis B flares: a nationwide population-based cohort study. J. Inflamm. Res. 15, 2983-2993.
  267. Tsegay, L. and Ayano, G. (2020) The prevalence of suicidal ideation and attempt among young people with HIV/AIDS: a systematic review and meta-analysis. Psychiatr. Q. 91, 1291-1304.
  268. Tsutsumi, T., Matsuda, M., Aizaki, H., Moriya, K., Miyoshi, H., Fujie, H., Shintani, Y., Yotsuyanagi, H., Miyamura, T., Suzuki, T. and Koike, K. (2009) Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology 50, 378-386.
  269. Turk, M. C., Bakker, C. J., Spencer, S. M. and Lofgren, S. M. (2022) Systematic review of sex differences in the relationship between hormones and depression in HIV. Psychoneuroendocrinology 138, 105665.
  270. Udina, M., Hidalgo, D., Navines, R., Forns, X., Sola, R., Farre, M., Capuron, L., Vieta, E. and Martin-Santos, R. (2014) Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J. Clin. Psychiatry 75, e1113-e1121.
  271. Vadaq, N., Zhang, Y., Meeder, E., Van de Wijer, L., Gasem, M. H., Joosten, L. A., Netea, M. G., de Mast, Q., Matzaraki, V., Schellekens, A., Fu, J. and van der Ven, A. J. (2022) Microbiome-related indole and serotonin metabolites are linked to inflammation and psychiatric symptoms in people living with HIV. Int. J. Tryptophan Res. 15, 11786469221126888.
  272. Vastag, L., Koyuncu, E., Grady, S. L., Shenk, T. E. and Rabinowitz, J. D. (2011) Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 7, e1002124.
  273. Vindegaard, N., Petersen, L. V., Lyng-Rasmussen, B. I., Dalsgaard, S. and Benros, M. E. (2021) Infectious mononucleosis as a risk factor for depression: a nationwide cohort study. Brain Behav. Immun. 94, 259-265.
  274. Vollmer-Conna, U., Fazou, C., Cameron, B., Li, H., Brennan, C., Luck, L., Davenport, T., Wakefield, D., Hickie, I. and Lloyd, A. (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol. Med. 34, 1289-1297.
  275. Volmer, R., Prat, C. M., Le Masson, G., Garenne, A. and Gonzalez-Dunia, D. (2007) Borna disease virus infection impairs synaptic plasticity. J. Virol. 81, 8833-8837.
  276. Vreeman, R. C., McCoy, B. M. and Lee, S. (2017) Mental health challenges among adolescents living with HIV. J. Int. AIDS Soc. 20, 21497.
  277. Wang, C., Cui, C., Xie, X., Chen, B., Feng, L. and Jiang, P. (2024a) Calcitriol attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behaviors by suppressing the P2X7R/NLRP3/caspase-1 pathway. Psychopharmacology (Berl.) 241, 1329-1343.
  278. Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G. and Yang, J. (2022) Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J. Neuroinflammation 19, 132.
  279. Wang, S., Zhang, H., Liu, R., Han, P., Yang, Q., Cheng, C., Chen, Y., Rong, Z., Su, C., Li, F., Wei, G., Zhao, M. and Yang, L. (2024b) Influenza A virus PB1-F2 induces affective disorder by interfering synaptic plasticity in hippocampal dentate gyrus. Mol. Neurobiol. 61, 8293-8306.
  280. Wang, X., Zhang, L., Lei, Y., Liu, X., Zhou, X., Liu, Y., Wang, M., Yang, L., Zhang, L., Fan, S. and Xie, P. (2014) Meta-analysis of infectious agents and depression. Sci. Rep. 4, 4530.
  281. Wang, Y., Cai, X., Ma, Y., Yang, Y., Pan, C. W., Zhu, X. and Ke, C. (2024c) Metabolomics on depression: a comparison of clinical and animal research. J. Affect. Disord. 349, 559-568.
  282. Watson, A. M., Prasad, K. M., Klei, L., Wood, J. A., Yolken, R. H., Gur, R. C., Bradford, L. D., Calkins, M. E., Richard, J., Edwards, N., Savage, R. M., Allen, T. B., Kwentus, J., McEvoy, J. P., Santos, A. B., Wiener, H. W., Go, R. C., Perry, R. T., Nasrallah, H. A., Gur, R. E., Devlin, B. and Nimgaonkar, V. L. (2013) Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol. Med. 43, 1023-1031.
  283. Watson, Z. and Tang, S. J. (2022) Aberrant synaptic pruning in CNS diseases: a critical player in HIV-associated neurological dysfunction? Cells 11, 1943.
  284. Williams, D. W., Li, Y., Dastgheyb, R., Fitzgerald, K. C., Maki, P. M., Spence, A. B., Gustafson, D. R., Milam, J., Sharma, A., Adimora, A. A., Ofotokun, I., Fischl, M. A., Konkle-Parker, D., Weber, K. M., Xu, Y. and Rubin, L. H. (2021) Associations between antiretroviral drugs on depressive symptomatology in homogenous subgroups of women with HIV. J. Neuroimmune Pharmacol. 16, 181-194.
  285. Winter, C., Reutiman, T. J., Folsom, T. D., Sohr, R., Wolf, R. J., Juckel, G. and Fatemi, S. H. (2008) Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism. Eur. Neuropsychopharmacol. 18, 712-716.
  286. Wong, A. C., Devason, A. S., Umana, I. C., Cox, T. O., Dohnalova, L., Litichevskiy, L., Perla, J., Lundgren, P., Etwebi, Z., Izzo, L. T., Kim, J., Tetlak, M., Descamps, H. C., Park, S. L., Wisser, S., McKnight, A. D., Pardy, R. D., Kim, J., Blank, N., Patel, S., Thum, K., Mason, S., Beltra, J. C., Michieletto, M. F., Ngiow, S. F., Miller, B. M., Liou, M. J., Madhu, B., Dmitrieva-Posocco, O., Huber, A. S., Hewins, P., Petucci, C., Chu, C. P., Baraniecki-Zwil, G., Giron, L. B., Baxter, A. E., Greenplate, A. R., Kearns, C., Montone, K., Litzky, L. A., Feldman, M., Henao-Mejia, J., Striepen, B., Ramage, H., Jurado, K. A., Wellen, K. E., O'Doherty, U., Abdel-Mohsen, M., Landay, A. L., Keshavarzian, A., Henrich, T. J., Deeks, S. G., Peluso, M. J., Meyer, N. J., Wherry, E. J., Abramoff, B. A., Cherry, S., Thaiss, C. A. and Levy, M. (2023) Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851-4867.e20.
  287. Wouk, J., Rechenchoski, D. Z., Rodrigues, B. C. D., Ribelato, E. V. and Faccin-Galhardi, L. C. (2021) Viral infections and their relationship to neurological disorders. Arch. Virol. 166, 733-753.
  288. Wu, M. K., Huang, T. L., Huang, K. W., Huang, Y. L. and Hung, Y. Y. (2015) Association between toll-like receptor 4 expression and symptoms of major depressive disorder. Neuropsychiatr. Dis. Treat. 11, 1853-1857.
  289. Yamanashi, H., Akabame, S., Miyata, J., Honda, Y., Nonaka, F., Shimizu, Y., Nakamichi, S., Kawashiri, S. Y., Tamai, M., Arima, K., Kawakami, A., Aoyagi, K. and Maeda, T. (2022) Association between Epstein-Barr virus serological reactivation and psychological distress: a cross-sectional study of Japanese community-dwelling older adults. Aging (Albany N.Y.) 14, 8258-8269.
  290. Yao, Y., Gu, J., Li, M., Li, G., Ai, J. and Zhao, L. (2023) WHSC1L1-mediated epigenetic downregulation of VMP1 participates in herpes simplex virus 1 infection-induced mitophagy impairment and neuroinflammation. Mol. Immunol. 163, 63-74.
  291. Yaow, C. Y. L., Hong, A. S. Y., Chong, N. Z., Chong, R. I. H., Mai, A. S. and Tan, E. K. (2023) Risk of Parkinson's disease in hepatitis B and C populations: a systematic review and meta-analysis. J. Neural Transm. (Vienna) 131, 609-616.
  292. Ye, J., Wen, Y., Chu, X., Li, P., Cheng, B., Cheng, S., Liu, L., Zhang, L., Ma, M., Qi, X., Liang, C., Kafle, O. P., Jia, Y., Wu, C., Wang, S., Wang, X., Ning, Y. and Zhang, F. (2020) Association between herpes simplex virus 1 exposure and the risk of depression in UK Biobank. Clin. Transl. Med. 10, e108.
  293. Yirmiya, R., Rimmerman, N. and Reshef, R. (2015) Depression as a microglial disease. Trends Neurosci. 38, 637-658.
  294. Yong, S. J., Yong, M. H., Teoh, S. L., Soga, T., Parhar, I., Chew, J. and Lim, W. L. (2021) The hippocampal vulnerability to herpes simplex virus type I infection: relevance to Alzheimer's disease and memory impairment. Front. Cell. Neurosci. 15, 695738.
  295. Yu, K., Qiu, C. L., Yang, G. B., Zong, C. M., Xing, H., Shao, Y., Wei, Q. and Qin, C. (2010) Alteration of serotonin transporter messenger RNA level in the peripheral blood mononuclear cells from simian/human immunodeficiency virus infected Chinese rhesus macaques (Macaca mulatta). Brain Behav. Immun. 24, 298-305.
  296. Yu, X., Wang, S., Wu, W., Chang, H., Shan, P., Yang, L., Zhang, W. and Wang, X. (2023) Exploring new mechanism of depression from the effects of virus on nerve cells. Cells 12, 1767.
  297. Yuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C. and Zhang, W. (2023) Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. Signal Transduct. Target. Ther. 8, 309.
  298. Zaletel, I., Filipovic, D. and Puskas, N. (2017) Hippocampal BDNF in physiological conditions and social isolation. Rev. Neurosci. 28, 675-692.
  299. Zareifopoulos, N., Lagadinou, M., Karela, A., Kyriakopoulou, O. and Velissaris, D. (2020a) Neuropsychiatric effects of antiviral drugs. Cureus 12, e9536.
  300. Zareifopoulos, N., Lagadinou, M., Karela, A., Pouliasi, F., Economou, I., Tsigkou, A. and Velissaris, D. (2020b) Efavirenz as a psychotropic drug. Eur. Rev. Med. Pharmacol. Sci. 24, 10729-10735.
  301. Zhang, X. H., Shi, J. Y., Zhan, C., Zhang, L. and Chen, H. J. (2020) Intrinsic brain abnormalities in patients with hepatitis C virus infection with cognitive impairment: a preliminary resting-state fMRI study. Biomed Res. Int. 2020, 1693043.
  302. Zheng, H., Ford, B. N., Kuplicki, R., Burrows, K., Hunt, P. W., Bodurka, J., Kent Teague, T., Irwin, M. R., Yolken, R. H., Paulus, M. P. and Savitz, J. (2021) Association between cytomegalovirus infection, reduced gray matter volume, and resting-state functional hypoconnectivity in major depressive disorder: a replication and extension. Transl. Psychiatry 11, 464.
  303. Zheng, H. and Savitz, J. (2023) Effect of cytomegalovirus infection on the central nervous system: implications for psychiatric disorders. Curr. Top. Behav. Neurosci. 61, 215-241.
  304. Zheng, H., Webster, M. J., Weickert, C. S., Beasley, C. L., Paulus, M. P., Yolken, R. H. and Savitz, J. (2023) Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples. Mol. Psychiatry 28, 5282-5292.
  305. Zheng, X. X., Zhang, C. F., Li, L. Q., Ye, J. R., Ren, S. Y., Zhang, Z., He, X., Chu, S. F. and Chen, N. H. (2024) Improvement of astrocytic gap junction involves the anti-depressive effect of celecoxib through inhibition of NF-κB. Brain Res. Bull. 207, 110871.
  306. Zhou, S., Liu, Y., Xue, B. and Yuan, P. (2024) Low-dose Esketamine suppresses NLRP3-mediated apoptotic and pyroptotic cell death in microglial cells to ameliorate LPS-induced depression via ablating GSK-3β. Behav. Brain Res. 459, 114782.
  307. Zhu, C., Zhang, T., Li, Q., Chen, X. and Wang, K. (2023) Depression and anxiety during the COVID-19 pandemic: epidemiology, mechanism, and treatment. Neurosci. Bull. 39, 675-684.
  308. Zhu, J., Mactutus, C. F., Wallace, D. R. and Booze, R. M. (2009) HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J. Pharmacol. Exp. Ther. 329, 1071-1083.
  309. Zhu, J., Yuan, Y., Midde, N. M., Gomez, A. M., Sun, W. L., Quizon, P. M. and Zhan, C. G. (2016) HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. J. Neurovirol. 22, 282-292.
  310. Zhu, P., Chen, Y. J., Hao, J. H., Ge, J. F., Huang, K., Tao, R. X., Jiang, X. M. and Tao, F. B. (2013) Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy. Sci. Rep. 3, 3096.
  311. Zignego, A. L., Cozzi, A., Carpenedo, R., Giannini, C., Rosselli, M., Biagioli, T., Aldinucci, A., Laffi, G. and Moroni, F. (2007) HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. Dig. Liver Dis. 39 Suppl 1, S107-S111.
  312. Zurcher, S. J., Banzer, C., Adamus, C., Lehmann, A. I., Richter, D. and Kerksieck, P. (2022) Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates. J. Infect. Public Health 15, 599-608.